The Identification and Characterization of Autonomic Dysfunction in Migraineurs With and Without Auras
NCT01080287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2012-02-22
Summary
This is a study to compare subject response and symptoms resulting from administration of three clinical assessments.
\* The 3 assessments are
1. passive upright tilt table testing,
2. quantitative sudomotor axon reflex testing (QSART)and
3. punch biopsy.
The comparison of results will be from two subject groups:
* Group A, the migraine suffering patient with or without aura
* Group B, the migraine suffering patient with or without aura who has diagnosed orthostatic intolerance (i.e.,feeling dizzy or faint when making a body position change).
Conditions
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Treatment of Episodic Migraine With AURICular Neuromodulation
NCT06623188 ·Status: RECRUITING ·Phase: NA
-
Migraine Attack Pain Phase Prediction Study
NCT06459635 ·Status: RECRUITING
-
Defining the Sympathetic Skin Response of Migraineurs in the Facial Area
NCT03772860 ·Status: UNKNOWN
-
Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
NCT00893594 ·Status: UNKNOWN ·Phase: NA
-
Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study
NCT06868953 ·Status: NOT_YET_RECRUITING
-
Study With Migraid Device in Acute, Early Treatment of Migraine With Typical Aura
NCT00126035 ·Status: COMPLETED ·Phase: NA
-
An Acute Migraine Factorial Study
NCT06245902 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine
NCT02867709 ·Status: COMPLETED ·Phase: PHASE3
-
Autonomic Dysfunction in Patients With Migraine: Cardiovascular and Neurophysiology Assessment
NCT06798259 ·Status: ACTIVE_NOT_RECRUITING
-
Electrical Stimulation of the Sphenopalatine Ganglion for the Treatment of Migraine Headaches
NCT01294046 ·Status: COMPLETED ·Phase: NA
-
Brain Connectome for Acupuncture-treated Migraine Patients
NCT04157192 ·Status: UNKNOWN ·Phase: NA
-
An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine
NCT02873221 ·Status: COMPLETED ·Phase: PHASE3
-
CGRP Inhibition, Autonomic Function, and Migraine
NCT04628429 ·Status: RECRUITING
-
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725 ·Status: COMPLETED ·Phase: NA
-
Brain Perfusion Assessment in the Acute Phase of Migraine Aura
NCT03821584 ·Status: TERMINATED
-
Migraine and Neuropathic Pain in Osteoarthritis
NCT06224959 ·Status: RECRUITING
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
NCT04299958 ·Status: COMPLETED
-
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura
NCT04063540 ·Status: RECRUITING ·Phase: PHASE2
-
QST, Blink Reflex and Nociceptive Flexion Reflex in Headache
NCT04585698 ·Status: UNKNOWN
-
Botox Injection in Treatment of Chronic Migraine
NCT02259075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oxygenation and Perfusion in Patients With Acute Migraine Attacks
NCT03536936 ·Status: COMPLETED
-
Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea
NCT03185143 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Migraine With and Without Aura Characteristics and Response to Remote Electrical Neuromodulation (REN) Treatment
NCT06023953 ·Status: COMPLETED
-
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)
NCT00382993 ·Status: COMPLETED ·Phase: PHASE3